Ethics statement
DEL
The study was designed in agreement with the Declaration of Helsinki/Tokyo. All procedures involving human subjects were approved by the Clinical Research Ethics Committee of the Jordi Gol University Institute for Primary Care Research (Institut d'Investigació en Atenció Primària), the Pere Virgili Health Research Institute (Institut d'Investigació Sanitària Pere Virgili) and of the Spanish Agency for Medicines and Medical Devices (Agencia Española del Medicamento y Productos Sanitarios). Signed informed consent was obtained from all women participating in the study. The quality of the present population‐based randomized controlled trial has been assessed by the Consolidated Standards of Reporting Trials.